Supira Medical

Supira Medical

Private
Los Gatos, CaliforniaHealthcare & Life Scienceshttps://www.supiramedical.com

Last Round

Series E

Mar 26, 2025

Total Funding Raised

$240.5M

Momentum Score

25 /100

Company Overview

Supira Medical is a medical device company that develops a percutaneous ventricular assist device aimed at providing temporary mechanical support for patients experiencing cardiogenic shock due to severe coronary artery disease or related conditions.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription

AI Layer

Non-AI

Keywords

percutaneous ventricular assist devicepVADmechanical circulatory supportMCStemporary heart pumphemodynamic supporthigh-risk PCIcardiogenic shockventricular assist deviceprotected PCIsmall bore accessinterventional cardiologycath lab deviceclinical-stage medical device

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Supira Medical Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Supira Medical Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series EMar 26, 2025
Series DNov 21, 2023
Series CFeb 28, 2022
Series BFeb 25, 2020
Series AApr 25, 2018

Key People

Founding team and executive leadership

Nitin Salunke

President CEO Member Of The Board Of Directors

Executive Team

Supira Medical Investors

Notable investors and investment history

InvestorRounds
ShifamedSeries C, Series D, Series B
415Series C, Series B, Series E
415 CapitalSeries C, Series D, Series B, Series E
Unorthodox VenturesSeries D, Series E
Cormorant CapitalSeries E
The Capital PartnershipSeries B, Series E, Series C, Series D, Series A
Novo HoldingsSeries E

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 8, 2026

    D. Keith Grossman appointed to the Board of Directors.

  • Apr 8, 2026

    Received FDA approval to initiate the SUPPORT II Pivotal Trial for its pVAD.

Supira Medical Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Supira Medical Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Supira Medical's valuation, stock price, and market status.

Firmographic Details

HeadquartersLos Gatos, California
Employee Range125
Year Founded2016
Last FundingMar 26, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.